Feed MBG.WA
MB

Mercedes-Benz Group AG MBG.WA · WSE

187.50 zł +2.08% (+3.82 zł)

Summary

47 / 100 · Bulios Score

What speaks for it

  • It has been profitable 6 years in a row.
  • It passes 8 of the 9 points of the Piotroski financial health test.

What to watch

  • Earnings per share fell by 56% a year over the last 3 years.
  • Repaying its net debt would take 6.0 years of operating profit.
  • It cut its dividend by 20% last year.
  • The share price is above the Bulios Fair Price.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price 187.5 zł
P/E today 7.4 13% higher
5-year average P/E 6.5
P/E today 7.4
Auto - Manufacturers industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 7.4 EUR for 1 EUR of yearly profit. Over the last five years it was 6.5 EUR on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (EUR)

Diluted EPS (EUR)

  • Analyst estimate

Revenue grew by 1.7% a year over 5 years. Over the last 3 years it fell by 4.1% a year. For the next fiscal year analysts expect revenue to fall by 2.0%. Earnings per share fell by 56% a year over the last 3 years.

Growth in detail

Does it make money?

Poorly

Where 100 EUR of revenue goes

Net profit, industry median (Auto - Manufacturers) 2.8 EUR

Out of every 100 EUR of revenue, 4.2 EUR is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Repaying all its debt would take 19.9 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

High, stretched
Yield
8.07%
Paid out of profit
60%

You receive 14.83 zł per share a year. The payout takes a large part of its profit or free cash flow.

Dividends in detail

What do analysts expect?

Mildly positive

No analyst has published a price target.

100% of the analysts recommend buying.

Analysts in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy